New to Medtech Insight?
Start a free trial today!
Register for our free email digests:
Register for our free email digests:
Brought to you by

DexCom Inc.'s Series C brings in $30mm
08 Jan 2007
Executive Summary
DexCom Inc. (developing an implantable glucose monitor for diabetics) raised $30mm in its third financing round, which was led by RWI Group.
Deal Industry
- In Vitro Diagnostics
-
Medical Devices
- Implantable Devices
-
In Vitro Diagnostics
- Biosensors
- Glucose Testing
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com